Mostaqimur Rahman^1*, Hafiza Sultana¹, Abdullahil Mosawuir², Latifa Akhter³, Abdullah Yusuf⁴

Show more
¹ Department of Microbiology, Rangpur Medical College, Rangpur, Bangladesh.
² Department of Physiology, Rangpur Medical College, Rangpur, Bangladesh.
³ Department of Skin & VD, Rangpur Medical College, Rangpur, Bangladesh.
⁴ Department of Microbiology, National Institute of Neuroscience & Hospital, Dhaka, Bangladesh.
Show less

Abstract: Background: Detection of extended spectrum beta lactamase producing bacteria is an important issue in the clinical settings. Objective: The purpose of the present study was to validate the Cica Beta Test 1 for detection of extended spectrum beta-lactamase (ESBL) producing bacteria. Method: This analytical type of cross-sectional study was carried out in the Department of Microbiology and Immunology at Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from January 2006 to December 2006 for a period of one (01) year. All the patients presented with the clinical features of urinary tract infection and surgical as well as burn wound infection at any age with both sexes were selected as study population. All bacteria were isolated and identified by their colony morphology, staining characters, pigment production, motility and other relevant biochemical tests. Phenotypic confirmation of ESBLs producing isolates were done by inhibitor potentiated disc diffusion test according to CLSI recommendation. The Cica Beta Test 1 was performed according to the manufacturer’s instructions. Result: A total number of 288 Gram negative bacteria were isolated. Among these isolates Cica Beta test 1 was positive in 97 strains and phenotypic confirmatory test was positive in 89 strains. The test sensitivity of Cica Beta Test 1 was 100% (95% CI 95.9% to 100.0%). Specificity of the test was 96.0% (95% CI 92.2% to 98.2%). The positive predictive value (PPV) and negative predictive value (NPV) were 92.7% (95% CI 84.5% to 95.7%) and 100.0% (95% CI 98.0% to 100.0%) respectively. The accuracy of the test was 97.2% (95% CI 95.1% to 99.1%). Area under ROC curve = 0.980 (95% CI 0.964 to 0.996); p value 0.0001. Conclusion: In conclusion, Cica Beta Test 1 is very high sensitivity and specificity for the detection of ESBL from Gram negative bacteria.

Keywords: Diagnostic Validity, Cica Beta Test 1, Extended Spectrum Beta-Lactamase, ESBL, Gram Negative Bacteria, Phenotypic Method

Cite this paper: Rahman, M. , Sultana, H. , Mosawuir, A. , Akhter, L. and Yusuf, A. (2019) Diagnostic Validity of Cica Beta Test 1 for the Detection of Extended Spectrum Beta-Lactamase (ESBL) Producing Gram Negative Bacteria by Comparing with Phenotypic Method. Advances in Infectious Diseases, 9, 39-48. doi: 10.4236/aid.2019.91004.

References

[1]   Linscott, A.J. and Brown, W.J. (2005) Evaluation of Four Commercially Extended Spectrum Beta-Lactamases Phenotypic Confirmatory Tests. Journal of Clinical Microbiology, 43, 1081-1085.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1081251/
https://doi.org/10.1128/JCM.43.3.1081-1085.2005

[2]   Bradford, P.A. (2001) Extended-Spectrum β-Lactamase in 21st Century: Characterization, Epidemiology and Detection of This Important Rasistance Threat. Clinical Microbiology Reviews, 14, 933-951.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89009/
https://doi.org/10.1128/CMR.14.4.933-951.2001

[3]   Lin, C.-F., Hsu, S.-K., Chen, C.-H., Huang, J.-R. and Lo, H.-H. (2010) Genotypic Detection and Molecular Epidemiology of Extended Expectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumonia in a Regional Hospital in Central Taiwan. Journal of medical Microbiology, 59, 665-671.
https://www.ncbi.nlm.nih.gov/pubmed/20150317
https://doi.org/10.1099/jmm.0.015818-0

[4]   Colodner, R., Reznik, B., Gal, V., Yamazaki, H., Hanaki, H. and Kubo, R. (2006) Evaluation of a Novel Kit for the Rapid Detection of Extended-Spectrum Beta-Lactamases. European Journal of Clinical Microbiology and Infectious Diseases, 25, 49-51.
https://doi.org/10.1007/s10096-005-0074-y

[5]   National Committee for Clinical Laboratory Standards (1999) Performance Standards for Antimicrobial Susceptibility Testing. NCCLS Approved Standard, M100-S9, National Committee for Clinical Laboratory Standards, Wayne.
https://www.scirp.org/(S(i43dyn45teexjx455qlt3d2q))/reference/ReferencesPapers.aspx?ReferenceID=1145440

[6]   Karim, A. and Parvez (2002) Emerging Multi-Drug Resistant Organism in Tertiary Care Hospital of Dhaka City. Bangladesh Journal of Medical Science, 8, 53-57.

[7]   Thomson, K.S. Controversies about Extended-Spectrum and AmpC Beta-Lactamases’ Special Issue. 1-16.

[8]   Alim, R. (2005) Detection of Extended Spectrum β-Lactamase (ESBL) Producing Bacteria. Thesis, BSMMU.

[9]   Rahman, M., Haq, J.A., Hossain, M.A., Sultana, R., Islam, F. and Islam, S. (2004) Prevelance of Extended-Spectrum b-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in an Urban Hospital in Dhaka, Bangladesh. Antimicrobial Agents, 24, 508-510.
https://www.ncbi.nlm.nih.gov/pubmed/15519486

[10]   Foury and Araj, G.F. (2003) Recent Developments in β-Lactamases and Extended Sepectrum β-Lactamases. Bangladesh Medical Journal, 327, 1209-1213.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC274061/

[11]   Chlebicki, M.P. and Oh, H.M. (2004) Extended-Spectrum Beta-Lactamases in Clinical Isolates of Escherichia coli and Klebsiella spp. in a Singapore Hospital. Annals Academy of Medicine Singapore, 33, 302-306.
https://www.ncbi.nlm.nih.gov/pubmed/15175768

[12]   Podschun, R. and Ullmann (1998) Klebsiella spp., as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clinical Microbiology Reviews, 11, 589-603.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88898/
https://doi.org/10.1128/CMR.11.4.589

[13]   Consensus Guidelines for Management of Infections by ESBL-Producing Bacteria, Ministry of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Society of Infectious Diseases and Chemotherapy, 2001.

[14]   Bush, K., Jacoby, G.A. and Medeiros, A.A. (1995) A Functional Classification Scheme for β-Lactamases and Its Correlation with Molecular Structure. Antimicrob Agents Chemotherapy, 39, 1211-1233.
https://www.ncbi.nlm.nih.gov/pubmed/7574506